Adamis Pharmaceuticals Corporation carries a market capitalization of 7.25M, placing it among publicly traded companies globally.
| Market Cap | 7.25M |
| Enterprise Value | N/A |
Adamis Pharmaceuticals Corporation's stock has declined approximately -91.43646% over the past 52 weeks. The 50-day moving average sits at 0.90, while the 200-day moving average is 6.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -91.43646% |
| 50-Day Moving Average | 0.90 |
| 200-Day Moving Average | 6.11 |
| Average Volume (20 Days) | N/A |
Adamis Pharmaceuticals Corporation's most recent stock split took place on May 22, 2023 with a 70:1 split ratio.
| Last Split Date | 5/22/2023 |
| Split Ratio | 70:1 |